Impact of Quinolone Restriction on Resistance Patterns of Escherichia coli Isolated from Urine by Culture in a Community Setting

被引:97
作者
Gottesman, Bat Sheva [1 ,2 ]
Carmeli, Yehuda [2 ,3 ]
Shitrit, Pnina [1 ,2 ]
Chowers, Michal [1 ,2 ]
机构
[1] Meir Med Ctr, Infect Dis Unit, IL-44281 Kefar Sava, Israel
[2] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-69978 Tel Aviv, Israel
关键词
GROUP-A STREPTOCOCCI; TRACT-INFECTIONS; KLEBSIELLA-PNEUMONIAE; BIOLOGICAL COST; FLUOROQUINOLONES; SUSCEPTIBILITY; ERYTHROMYCIN; CONSUMPTION; HOSPITALS;
D O I
10.1086/605530
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Decreased antimicrobial susceptibility after increased antibiotic use is a known phenomenon. Restoration of susceptibility once antimicrobial use is decreased is not self-evident. Our objective was to evaluate, in a community setting, the impact of quinolone restriction on the antimicrobial resistance of E. coli urine isolates. Methods. We conducted a retrospective, quasi-experimental ecological study to assess the proportion of quinolone-susceptible E. coli urine isolates in the periods before, during, and after a nationwide restriction on ciprofloxacin use was implemented. We used an interrupted time interval analysis for outcome evaluation. Results. We found a significant decline in quinolone consumption, measured as defined daily doses (DDDs) per month, between the preintervention and intervention periods (point estimate, -1827.3 DDDs per month; 95% confidence interval [CI], -2248.8 to -1405.9 DDDs per month; P < .001). This decline resulted in a significant P < .001 decrease in E. coli nonsusceptibility to quinolones, from a mean of 12% in the preintervention period to a mean of 9% in the intervention period (odds ratio, 1.35;). The improved susceptibility pattern reversed immediately when quinolone consumption rose. Moreover, a highly significant inverse relationship was found between the level of quinolone use (regardless of intervention period) and the susceptibility of E. coli urine isolates to quinolone (odds ratio, 1.70; 95% CI, 1.26-2.28). During the months of highest quinolone use (8321 DDDs per month), the proportion of nonsusceptibility was 14%, whereas during the months of lowest quinolone use (4027 DDDs per month), the proportion of nonsusceptibility was 9%. An average decrease in resistance of 1.16% was observed for each decrease of 1000 DDDs. Conclusion. Reducing quinolone consumption can lead to an immediate increase in the susceptibility of E. coli urine isolates to quinolones.
引用
收藏
页码:869 / 875
页数:7
相关论文
共 24 条
[1]  
Brahmi Nozha, 2006, Journal of Infection and Chemotherapy, V12, P190, DOI 10.1007/s10156-006-0452-0
[2]   Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae [J].
Chiew, YF ;
Yeo, SF ;
Hall, LMC ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (02) :247-251
[3]  
Davey P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003543.pub2, 10.1002/14651858.CD003543.pub3]
[4]  
ELDEEN AS, 1988, APMIS, V3, P59
[5]   The effect of an antimicrobial formulary change on hospital resistance patterns [J].
Empey, KM ;
Rapp, RP ;
Evans, ME .
PHARMACOTHERAPY, 2002, 22 (01) :81-87
[6]   Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element [J].
Enne, VI ;
Delsol, AA ;
Davis, GR ;
Hayward, SL ;
Roe, JM ;
Bennett, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (03) :544-551
[7]   Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction [J].
Enne, VI ;
Livermore, DM ;
Stephens, P ;
Hall, LMC .
LANCET, 2001, 357 (9265) :1325-1328
[8]   European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe [J].
Ferech, Matus ;
Coenen, Samuel ;
Malhotra-Kumar, Surbhi ;
Dvorakova, Katerina ;
Hendrickx, Erik ;
Suetens, Carl ;
Goossens, Herman .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) :423-427
[9]  
FINLAND M, 1955, NEW ENGL J MED, V253, P909, DOI 10.1056/NEJM195512012532206
[10]   Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands [J].
Goettsch, W ;
van Pelt, W ;
Nagelkerke, N ;
Hendrix, MGR ;
Buiting, AGM ;
Petit, PL ;
Sabbe, LJM ;
van Griethuysen, AJA ;
de Neeling, AJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (02) :223-228